The change affects the company name, instrument name and FISN. The share will be traded under the new name as of August 24, 2023.

Information about the share:

New company name: Hamlet BioPharma AB (publ)
Previous Company name: Hamlet Pharma AB
LEI (unchanged): 549300HJV2LJY4CDBR64
Company registration number (unchanged): 556568-8958
New instrument name: Hamlet BioPharma B
Previous instrument name: Hamlet Pharma B
Short name (unchanged):  HAMLET B
ISIN-number (unchanged): SE0015661152
Orderbook ID (unchanged): 413D
CFI (unchanged): ESVUFR
New FISN: HAMLETBIOP/SH B
Previous FISN: HAMLETPHAR/SH B
First date of trade with new name: August 24, 2023

Stockholm August 21, 2023

Spotlight Stock Market
08-511 68 000 
backoffice@spotlightstockmarket.com